🕵️ Inmed Pharmaceuticals Inc. ($INM)
SEC insider & ownership activity, last 12 months · CIK 1728328 · every row links its SEC filing
Over the last 12 months insiders bought $1.2M with no open-market selling against it. ADAR1 Capital Management, LLC bought $723K (May–Jul). One red-flag 8-K in the window: Delisting notice (3.01), Mar 27, 2026.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
2 buyers, $1.2M (34 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| ADAR1 Capital Management, LLC | 4 | $723K | 0 | – | Jul 15, 2026 |
| VIVO Opportunity, LLC | 30 | $434K | 0 | – | Jul 16, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| ADAR1 Capital Management, LLC | 24.1% | 13G | Jun 5, 2026 | filing ↗ | |
| Daniel Schneeberger | 24.1% | 13G | Jun 5, 2026 | filing ↗ | |
| VIVO Opportunity, LLC | 21.7% | 13D | May 19, 2026 | filing ↗ | |
| VIVO Opportunity Fund Holdings, L.P. | 21.7% | 13D | May 19, 2026 | filing ↗ | |
| Sabby Management, LLC | 9.9% | 13G | Jan 20, 2026 | filing ↗ | |
| Hal Mintz | 9.9% | 13G | Jan 20, 2026 | filing ↗ | |
| Sabby Volatility Warrant Master Fund, Ltd. | 9.9% | 13G | Jan 20, 2026 | filing ↗ | |
| Squadron Master Fund LP | 9.8% | 13G | May 27, 2026 | filing ↗ | |
| Squadron Capital Management LLC | 9.8% | 13G | May 27, 2026 | filing ↗ | |
| Matthew Sesterhenn | 9.8% | 13G | May 27, 2026 | filing ↗ | |
| William Blank | 9.8% | 13G | May 27, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Reg FD disclosure (7.01) | Jul 22, 2026 | filing ↗ |
| Other events (8.01) | Jul 22, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 22, 2026 | filing ↗ |
| Material agreement (1.01) | Jul 6, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 6, 2026 | filing ↗ |
| Other events (8.01) | Jun 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 3, 2026 | filing ↗ |
| Material agreement (1.01) | May 19, 2026 | filing ↗ |
| Change of control (5.01) | May 19, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 19, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 19, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 19, 2026 | filing ↗ |
| Material agreement (1.01) | May 18, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | May 18, 2026 | filing ↗ |
| Other events (8.01) | May 18, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 18, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 6, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 21, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Apr 21, 2026 | filing ↗ |
| Other events (8.01) | Apr 21, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 21, 2026 | filing ↗ |
| Other events (8.01) | Apr 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 3, 2026 | filing ↗ |
| Delisting notice (3.01) | Mar 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 27, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 23, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 9, 2026 | filing ↗ |